
Pacira BioSciences, Inc. owns 1 brand in our database. Browse the complete portfolio of Pacira BioSciences, Inc. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Brisbane, California, USA
Brand Portfolio
1 brands
Stock
Nasdaq: PCRX
American pharmaceutical company focused on non-opioid pain therapies including EXPAREL and ZILRETTA, being acquired by Viatris for $1.65 billion in a deal announced October 2026.
No competing brands found in the same categories. This could be because Pacira BioSciences, Inc.operates in unique market segments or we're still building our competitor database.
Pacira BioSciences, Inc. maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Pacira BioSciences, Inc.provides valuable insights into market dynamics, product relationships, and corporate strategy.